Drug related policies expected to undergo major changes (first part)

Published: 2008-02-01 07:00:00

Updated: 2008-02-01 07:00:00

Under the incoming Lee Myung-bak administration, scheduled to be inaugurated late next month, the country's pharmaceutical paradigm is expected to experience a major change from that of the incumbent Roh Moo-hyun administration.

The most drastic changes under his reign are likely to be the all...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK